Skip to main content
Erschienen in: Archives of Dermatological Research 5/2005

01.11.2005 | Original Paper

Identification of two novel mutations in Chinese patients with Dyschromatosis symmetrica hereditaria

verfasst von: Ming Li, Chengrang Li, Haikang Hua, Wenyuan Zhu, Yan Lu, Lijia Yang

Erschienen in: Archives of Dermatological Research | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Dyschromatosis symmetrica hereditaria (DSH) is a rare autosomal dominant cutaneous disorder characterized by a mixture of hyperpigmented and hypopigmented macules of various sizes on the extremities. Pathogenic mutations in the DSRAD gene have recently been identified. In this study, we report and identify the mutations of the DSRAD gene in two Chinese pedigrees with DSH. Two novel mutations in the functional domains of the DSRAD gene were identified and verified in two pedigrees. The c.3244A>G (H1075R) mutation was found in all patients but not in the healthy individuals from family A and c.3335_3336delAT (Y1112fs→1112X) mutation was found in three patients but not in the healthy family members from family B. Our data suggests that these two novel mutations in the DSRAD gene could cause DSH and add new variants to the repertoire of DSRAD mutations in DSH.
Literatur
1.
Zurück zum Zitat Ostlere LS, Ratnavel RC, Lawlor F, Black MM, Griffiths WA (1995) Reticulate acropigmentation of Dohi. Clin Exp Dermatol 20:477–479PubMedCrossRef Ostlere LS, Ratnavel RC, Lawlor F, Black MM, Griffiths WA (1995) Reticulate acropigmentation of Dohi. Clin Exp Dermatol 20:477–479PubMedCrossRef
2.
Zurück zum Zitat Toyama I (1929) Dyschromatosis symmetrica hereditaria. Jpn J Dermatol 27:95–96 Toyama I (1929) Dyschromatosis symmetrica hereditaria. Jpn J Dermatol 27:95–96
3.
Zurück zum Zitat Oyama M, Shimizu H, Ohata Y, Tajima S, Nishikawa T (1999) Dyschromatosis symmetrica hereditaria (reticulate acropigmentation of Dohi): report of a Japanese family with the condition and a literature review of 185 cases. Br J Dermatol 140:491–496CrossRefPubMed Oyama M, Shimizu H, Ohata Y, Tajima S, Nishikawa T (1999) Dyschromatosis symmetrica hereditaria (reticulate acropigmentation of Dohi): report of a Japanese family with the condition and a literature review of 185 cases. Br J Dermatol 140:491–496CrossRefPubMed
4.
Zurück zum Zitat Zhang XJ, Gao M, Li M, Li M, Li CR, Cui Y, He PP, Xu SJ, Xiong XY, Wang ZX, Yuan WT, Yang S, Huang W (2003) Identification of a locus for dyschromatosis symmetrica hereditaria at chromosome 1q11–1q21. J Invest Dermatol 120:776–780CrossRefPubMed Zhang XJ, Gao M, Li M, Li M, Li CR, Cui Y, He PP, Xu SJ, Xiong XY, Wang ZX, Yuan WT, Yang S, Huang W (2003) Identification of a locus for dyschromatosis symmetrica hereditaria at chromosome 1q11–1q21. J Invest Dermatol 120:776–780CrossRefPubMed
5.
Zurück zum Zitat Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, Tomita Y (2003) Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet 73:693–699CrossRefPubMed Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, Tomita Y (2003) Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet 73:693–699CrossRefPubMed
6.
Zurück zum Zitat Zhang XJ, He PP, Li M, He CD, Yan KL, Cui Y, Yang S, Zhang KY, Gao M, Chen JJ, Li CR, Jin L, Chen HD, Xu SJ, Huang W (2004) Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH). Hum Mutat 23:629–630CrossRefPubMed Zhang XJ, He PP, Li M, He CD, Yan KL, Cui Y, Yang S, Zhang KY, Gao M, Chen JJ, Li CR, Jin L, Chen HD, Xu SJ, Huang W (2004) Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH). Hum Mutat 23:629–630CrossRefPubMed
7.
Zurück zum Zitat Li M, Jiang YX, Liu JB,Yang S, He PP, Gao M, Wei SC, Yan KL, Huang W, Zhang XJ (2004) A novel mutation of the DSRAD gene in a Chinese family with Dyschromatosis symmetrica hereditaria. Clin Exp Dermatol 29:533–535CrossRefPubMed Li M, Jiang YX, Liu JB,Yang S, He PP, Gao M, Wei SC, Yan KL, Huang W, Zhang XJ (2004) A novel mutation of the DSRAD gene in a Chinese family with Dyschromatosis symmetrica hereditaria. Clin Exp Dermatol 29:533–535CrossRefPubMed
8.
Zurück zum Zitat Liu Q, Liu W, Jiang L, Sun M, Ao Y, Zhao X, Song Y, Luo Y, Lo WH, Zhang X (2004) Novel mutations of the RNA-specific adenosine deaminase gene (DSRAD) in Chinese families with dyschromatosis symmetrica hereditaria. J Invest Dermatol 122:896–899CrossRefPubMed Liu Q, Liu W, Jiang L, Sun M, Ao Y, Zhao X, Song Y, Luo Y, Lo WH, Zhang X (2004) Novel mutations of the RNA-specific adenosine deaminase gene (DSRAD) in Chinese families with dyschromatosis symmetrica hereditaria. J Invest Dermatol 122:896–899CrossRefPubMed
9.
Zurück zum Zitat Yang Y, Li S, Li H, Bu DF, Wang K, Tu P, Zhu XJ (2004)DSRAD gene mutation in three families with dyschromatosis symmetrica hereditaria. Beijing daxue xuebao 36:466–488 (in Chinese) Yang Y, Li S, Li H, Bu DF, Wang K, Tu P, Zhu XJ (2004)DSRAD gene mutation in three families with dyschromatosis symmetrica hereditaria. Beijing daxue xuebao 36:466–488 (in Chinese)
10.
Zurück zum Zitat Xing QH, Wang MT, Chen XD, Feng GY, Ji HY, Yang JD, Gao JJ, Qin W, Qian XQ, Wu SN, He L (2003) A gene locus responsible for dyschromatosis symmetrica hereditaria (DSH) maps to chromosome 6q24.2-q25.2. Am J Hum Genet 73:377–382CrossRefPubMed Xing QH, Wang MT, Chen XD, Feng GY, Ji HY, Yang JD, Gao JJ, Qin W, Qian XQ, Wu SN, He L (2003) A gene locus responsible for dyschromatosis symmetrica hereditaria (DSH) maps to chromosome 6q24.2-q25.2. Am J Hum Genet 73:377–382CrossRefPubMed
11.
Zurück zum Zitat O’Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, Jenny A, Keller W (1995) Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol 15:1389–1397PubMed O’Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, Jenny A, Keller W (1995) Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol 15:1389–1397PubMed
12.
Zurück zum Zitat Wang Y, Zeng Y, Murray JM, Nishikura K (1995) Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. J Mol Biol 254:184–195CrossRefPubMed Wang Y, Zeng Y, Murray JM, Nishikura K (1995) Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. J Mol Biol 254:184–195CrossRefPubMed
13.
Zurück zum Zitat Schade M, Turner CJ, Kuhne R, Schmieder P, Lowenhaupt K, Herbert A, Rich A, Oschkinat H (1999) The solution structure of the Zalpha domain of the human RNA editing enzyme ADAR1 reveals a prepositioned binding surface for Z-DNA. Proc Natl Acad Sci USA 96:12465–12470CrossRefPubMed Schade M, Turner CJ, Kuhne R, Schmieder P, Lowenhaupt K, Herbert A, Rich A, Oschkinat H (1999) The solution structure of the Zalpha domain of the human RNA editing enzyme ADAR1 reveals a prepositioned binding surface for Z-DNA. Proc Natl Acad Sci USA 96:12465–12470CrossRefPubMed
14.
Zurück zum Zitat Kim U, Wang Y, Sanford T, Zeng Y, Nishikura K (1994) Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci USA 91:11457–11461PubMedCrossRef Kim U, Wang Y, Sanford T, Zeng Y, Nishikura K (1994) Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci USA 91:11457–11461PubMedCrossRef
15.
Zurück zum Zitat Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279:4952–4961CrossRefPubMed Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279:4952–4961CrossRefPubMed
16.
Zurück zum Zitat Wang Q, Khillan J, Gadue P, Nishikura K (2000) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765–1768CrossRefPubMed Wang Q, Khillan J, Gadue P, Nishikura K (2000) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765–1768CrossRefPubMed
Metadaten
Titel
Identification of two novel mutations in Chinese patients with Dyschromatosis symmetrica hereditaria
verfasst von
Ming Li
Chengrang Li
Haikang Hua
Wenyuan Zhu
Yan Lu
Lijia Yang
Publikationsdatum
01.11.2005
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 5/2005
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-005-0595-3

Weitere Artikel der Ausgabe 5/2005

Archives of Dermatological Research 5/2005 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.